2023-03-31-accounts - The UK Oncology Nursing Society

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

The UK Oncology Nursing Society

Trustees’ Report

Year Ended 31 March 2023

The trustees have pleasure in presenting their report and the unaudited financial statements of the charitable company for the year ended 31 March 2023.

Status

The charitable company is limited by guarantee, having no share capital. Under the provisions of Section 60 of the Companies Act 2006, the company is entitled to omit the word "Limited" from its name. The governing document of the charitable company is its Memorandum and Articles of Association.

The charitable company is also known as UKONS.

Objects and Activities of the Charity

The objects of the charitable company are, for the public benefit:

To advance health and to relieve those in need by reason of ill-health, including without limitation people affected by cancer; and
To advance the education of the public in the subjects of health, medical and nursing care, including without limitation the causes, effects and treatments of cancer.

Aims of the charity

To promote excellence in the nursing care and management of all those directly and indirectly affected by cancer.
To encourage and facilitate the personal and professional development of nurses engaged in cancer care throughout the UK and overseas through education, research and policy.
To share information about research, learning and development opportunities with UKONS members.
To contribute to the development of cancer policy, clinical practice and service delivery nationally and internationally.
To foster alliances and develop UK and international networking opportunities.

Activities and achievements aligned to the charity’s aims for the year 2022/23

Continuation of the Members Interest Groups: Living with and Beyond Cancer; Acute Oncology Services; Systemic Anti-cancer Treatments; Radiotherapy; Haemato-oncology; Lead Cancer Nurses; Research and our newest Members Interest Group- ‘Young and Early Career Cancer Nurses’
Continuation of our provision of the UKONS website (www.ukons.org), catering to the needs of members and the members interest groups.
Continued publication of fortnightly editions of UKONS ‘Breaking News’ bulletin, supporting practice development and career progression, which is sent to all members via e-mail. This includes cancer nurse job advertisements for UKONS members. These advertisements are provided free of charge to advertisers.
During 2022/23 Breaking News continued to be delivered jointly between UKONS and Macmillan Cancer Care due to an ongoing and developing partnership. This was underpinned by an MOU agreed and signed by both parties, renewed in 2022.
In November 2022 we held our first face to face annual conference since the COVID pandemic in 2020. This was held in Belfast UK and was very successful with a record number of delegates registering and attending with the highest number of poster submissions ever received in UKONS history. The event focussed on a theme of ‘Cancer Care in the Digital Age’. This provided the opportunity for cancer nurses to discuss, and present posters on supportive cancer

The UK Oncology Nursing Society

Trustees’ Report

Year Ended 31 March 2023

care, communicating with patients in modern cancer care; and the future of acute cancer care. This year, as with the previous eight, the conference abstract booklet was made available to delegates. This

year it was again presented in electronic format and it is likely that it will continue to be produced in in this form annually.
UKONS continued to work with the Global Power of Oncology Nursing to support and facilitate their conference during 2023.
Work continued to produce a web-based version of the UKONS Systemic Anti-cancer Therapy (SACT) Competency Passport together with our partner is Tefogo Ltd. We aim to deliver this enhancement free to UKONS members during late 2023.
During 2022/23 UKONS continued to chair the UK SACT Board (formally UK Chemotherapy Board) delivering guidelines across all four nations for the delivery of systemic anti-cancer therapies
UKONS continued to be a central organisation in developing and delivering the ACCEND (Aspirant Cancer Career and Education Development) programme. This career framework provides guidance and structure or all health care professionals wishing to develop a career in cancer care.
Continued to approve translations of the UKONS Acute Oncology Triage Tool as well as working to formalise and deliver electronic versions of the tool.
UKONS worked in partnership with the UK Acute Oncology Society and Macmillan to standardise AO education, training and assessment and advanced work on multi-professional AO competency passports, these will be piloted in mid-2023.
Work commenced and continued on a book on the impact of the COVID pandemic in cancer care across Europe in partnership with Springer Press.
Organised and presented education, training sessions and symposia at virtual and face-to-face events for both UKONS and other organisations throughout the year, including the UK Oncology Forum and the Oncology Professional Care Conference.
Further developed the activities of UKONS Champions, with Young and Early Career Cancer Nurse input into a wide range of programmes and events. The champions worked to establish a sub-groups for both UKONS board alumni and Cancer Information Nurses.
In 2023 UKONS hosted the European Cancer Nursing Day in Edinburgh, Scotland in partnership with the European Oncology Nursing Society (EONS).
Continued to work with a wide range of industry partners and develop further relationships, extending our numbers of partners to more than 20.
Collaborated with: NHS England, UK Oncology Forum; British Journal of Nursing; Cancer Nursing Practice, The European Oncology Nursing Society (EONS); International Society of Nurses in Cancer Care (ISNCC); and Oncology Professional Care
Representation at the UK Chemotherapy Board; various NHS Working Groups (including those on SACT Capacity and Workforce); Macmillan Cancer Support/HEE.

Organisational Structure

The Board has four executive officers: President, Past President, Secretary and Treasurer. It has an additional ten full Board members who are all Trustees. New Trustees receive induction into their role on the Board.

Assessment of going concern

The charity’s income is reliant on sponsorship from UKONS Partners, Income has been maintained despite ongoing uncertainty related to the UK and global economy and the COVID-19 pandemic. The board maintain a cautious approach and these factors have been considered in budgeting resources for the next financial year.

The UK Oncology Nursing Society

Trustees’ Report

Year Ended 31 March 2023

Directors and Trustees

The directors and trustees who served the company during the year and up to the date of this report were as follows:

Mark Foulkes (President) Karen Campbell (President Elect) Lyndel Moore (Treasurer) Deborah Wightman (Secretary) Verna Lavender (Past President) Nalayini Kumaralingam Kay Bell Lisa Barrott Mark Foulkes Mary Tanay Libby Potter Joanne Bird Tracy Wilson Rosemary Roberts Naomi Clatworthy Ruth Hammond Constance Rowell

Reserves

The Trustees plan to retain a modest level of reserves as a contingency fund against future demands on the charity’s resources whilst using available funds to further our charitable aims.

Small Company Provisions

This report has been prepared in accordance with the special provisions for small companies under Part 15 of the Companies Act 2006.

Signed on behalf of the directors

Mark Foulkes Director

Approved on ……31[st] August 2023

The UK Oncology Nursing Society Unaudited Financial Statements Year Ended 31 March 2023 Company Registration Number 06996552 Charity Registration Number 1136972

The UK Oncology Nursing Society Financial Statements Year Ended 31 March 2023 Contents Page Trustees, Report Independent Examiner's Report Statement of Financial Activities Balance Sheet Notes to the Fin8nci81 Statements

The UK Oncology Nursing Society Trustees, Report Year Ended 31 March 2023 The Iruslees have pleasure in presenting their report and the unaudited financial stslemenls of the charitable company for the year ended 31 March 2023. Status The charitable company is limited by guarantee, having no share capital. Under the provisions of Section 60 of the Companies Act 2006, the company is entitled lo omit the word 'Limited' from ils name. The governing document of the charitsble company is ils Memorandum and Articles of Association. The charitable company is also known as UKONS. Objects and Activities of the Charity The objects of the charitable company are, for the PLJblic benefit.. To advance health and to relieve those in need by reason of ill-health, including without limitation people affected by cancer,. and To advance the education of the public in the subjects of health, medical and nursing care, including without limitation the causes, effects and treatments of cancer. Aims of the Charity To promote excellence in the nursing care and management of all those directly and indirectly affected by cancer. To encourage and facilitate the personal and professional development of nurses engaged in cancer care throughout the UK and overseas through education, research and policy. To share information about research, learning and development opportunities with UKONS members. To contribute to the development of cancer policy, clinical practice and service delivery nationally and internationally. To foster alliances and develop UK and international networking opportunities. Adivitigs and achiovgments aligned to the charity's aims for the year 2022123 Continuation of the Members Interest Groups.. Living with and Beyond Cancer., Acute Oncology Services,. Systemic Anti-cancer Treatments., Radiotherapy,. Haemato-oncology. Lead Cancer Nurses,. Research A further Members Interest Group- 'Young and Early Career Cancer Nurses, was added in 2021 and continues lo develop. Continuation of our provision of the UKONS website Iwww.ukons.org}, catering to the needs of members and the members interest groups Continued publication of fortnightly editions of UKONS 'Breaking News, bulletin, supporting practice development and career progression, which is sent to all members via e-mail. This includes cancer nurse job advertisements for UKONS members. These advertisements are provided free of charge lo advertisers. During 2022123 Breaking News continued lo be delivered jointly between UKONS and Macmillan Cancer Care due lo an ongoing and developing partnership. This was underpinned by an MOU agreed and signed by both parties, renewed in 2022. In November 2022 we held our first face to face annual Conferen since the COVID pandemic in 2020. This was held in Belfast UK and was very successful with a record number of delegates registering and allending with the highest number of poster submissions ever received in UKONS history. The event focussed on a theme of'cancer Care in the Digital Age,.

The UK Oncology Nursing Society Trustees, Report Icontinuedl Year Ended 31 March 2023 This provided the opportunity for cancer nurses to discuss, and present posters on supportive cancer care, communicating with patients in modern cancer care,. and the future of acute cancer care. This year, as with the previous eight, the conference abstract booklet was made available lo delegates. This year it was again presented in electronic formal and it is likely that it will continue lo be prodUd in in this form annually. UKONS continued lo work with the Global Power of Oncology Nursing lo support and facilitate their conference during 2023. Work continued lo prodLJce a web-based version of the UKONS Systemic Anti-cancer Therapy ISACTI Competency Passport together with our partner is Tefogo Ltd. We aim lo deliver this enhancement free to UKONS members during late 2023. During 2022123 UKONS continued to chair the UK SACT Board {formally UK Chemotherapy Board) delivering guidelines across all four nations for the delivery of systemic anli-cancer therapies UKONS continued to be a central organisation in developing and delivering the ACCEND IAspirant Canr Career and Education Development) programme. This career framework provides guidance and structure or all health care professionals wishing lo develop a career in cancer care. Continued to approve translations of the UKONS Acute Oncology Triage Tool as well as working to formalise and deliver electronic versions of the tool. UKONS worked in partnership with the UK Acute Oncology Society and Macmillan to slandardise AO education, training and assessment and advanced work on multi-professional AO competency passports, these will be piloted in mid-2023. Work commenced and continued on a book on the impact of the COVID pandemic in cancer care across Europe in partnership wrf(h Springer Press. Organised and presented education, training sessions and symposia at virtual and face-to-face events for both UKONS and other organisations throughout the year, including the UK Oncology Forum and the Oncology Professional Care Conference. Further developed the activities of UKONS Champions, with Young and Eady Career Cancer Nurse input into a wide range of programmes and events. The champions worked to establish a sub-groups for both UKONS board alumni and Cancer Information Nurses. In 2023 UKONS hosted the European Cancer Nursing Day in Edinburgh, Scotland in partnership with the European Oncology Nursing Society (EONSI. Continued lo work with a wide range of industry partners and develop further relationships, extending our numbers of partners lo more than 20. Collaborated with.. NHS England, UK Oncology Forum., British Journal of Nursing- Cancer Nursing Practice, The European Oncology Nursing Society IEONSI., International Society of Nurses in Cancer Care IISNCCI., and Oncology Professional Care Representation at the UK Chemotherapy Board., various NHS Working Groups (including those on SACT Capacity and Workforce)., Macmillan Cancer SupportlHEE. Organlsatlonal Structure The Board has four executive officers.. President, Past President, Secretary and Treasurer. It has an additional len full Board members who are all Trustees. New Trustees receive induction into their role on the Board. Assessment of going concern The charity's income is reliant on sponsorship from UKONS Partners, Income has been maintained despite ongoing uncertainty related lo the UK and global economy and the COVID-19 pandemic. The board maintain a cautious approach and these factors have been considered in budgeting resour$ for the next financial year.

The UK Oncology Nursing Society Trustees, Report Icontinuedl Year Ended 31 March 2023 Dlrectors and Trustees The directors and Iruslees who served the company during the year and up to the dale of this report were as follows= Mark Foulkes (Presidenti Karen Campbell (President Electi Lyndel Moore (Treasurer) (Appointed 11 November 20221 Deborah Wighlman Isecrelaryl Verna Lavender (Past Presidenti Nalayini Kumaralingam Kay Bell Lisa Barroti Mark Foulkes Mary Tanay Sam Wigfall Libby Potter Jo Bird Tracy Wilson Rosemary Roberts Naomi Clatworthy Ruth Hammond Constance Rowell Reserves The Trustees plan to relain a modest level of reserves as a contingency fund against future demands on the charity's resources. Small Company Provlslons This report has been prepared in accordance with the special provisions for small companies under Part 15 of the Companies Act 2006. Signed on behalf of the diredors Mark Foulkes Director Approved on . 1711112023

The UK Oncology Nursing Society Independent Examiner's Report to the Trustees Year Ended 31 March 2023 I report lo the charity Iruslees on my examination of the accounts of the Company for the year ended 31 March 2023. Rgsponsibilitigs and basis of rgport As the charity's Iruslees land also its directors for the purposes of company lawl you are responsible for the preparation of the accounts in accordance with the requirements of the Companies Act 2006 I'the 2006 Act'l. Having satisfied myself that the accounts of the Company are not required lo be audited under Part 16 of the 2006 Act and are eligible for independent examination, I report in respect of my examination of your charity's accounts as carried out under section 145 of the Charities Act 2011 {'Ihe 2011 Act'l. In carrying out my examination I have followed the Directions given by the Charity Commission under section 145{51 Ibl of the 2011 Act. Independent examiner's ststement I have completed my examination. I confirm that no matters have come lo my attention in connection with the examination giving me cause lo believe.. accounting records were not kept in respect of the Company as required by section 386 of the 2006 Act., or 2. the accounts do not accord with those records,. or 3. the accounts do not comply with the accounting requirements of section 396 of the 2006 Act other than any requirement that the accounts give a 'true and fair view, which is not a maller considered as part of an independent examination., or 4. the accounts have not been prepared in accordance with the methods and principles of the Statement of Recommended Practice for accounting and reporting by charities applicable to charities preparing their accounts in accordan with the Financial Reporting Standard applicable in the UK and Republic of Ireland IFRS 1021. I have no Concerns and have Come across no other matters in connection with the examination to which allenlion should be drawn in this report in order lo enable a proper understanding of the accounts lo be reached. Martln Hobbs Bsc ACA Francis Clark LLP Chartered Accountants Sigma House Oak View Close Edginswell Park Torquay TQ2 7FF Date.. 28 November 2023

The UK Oncology Nursing Society Statement of Financial Activities (incorporating an Income and Expenditure Account) Year Ended 31 March 2023 Unrestricted Funds Restricted Funds Total 2023 Total 2022 Income from: Partnership income Corporate membership Board activity Donations Other income 80,833 80,833 109,000 2,000 200 14,691 4,100 1,025 14,691 4,100 1,025 Total 100,649 100,649 111.210 Expenditure on.. EONS membership fee ISNCC membership fee EBN Health book Palliative care booklet Board meetings- Travel and subsistence Entertaininglother meetings MIGS Adminislralive support Secretarial services Legal and professional Annual conference Other conferences Slalionery and admin Website and social media Accounting fees Insurance SACT passport project Champions, workshop Irrecoverable VAT Grants Purchases 893 244 893 244 28 2,450 8,970 11,055 7,629 15.760 330 2.601 22,500 11,084 17 7.013 5.475 848 20.000 31 6,931 15,000 10,230 756 28 6.122 2,450 8,970 11,055 7,629 15,760 330 2,601 22,500 11,084 17 7.013 5.475 848 20.000 31 6.931 15,000 10,230 1,270 1,862 3,735 17,053 1,388 250 9,710 2,475 513 14,988 4,225 933 1,420 20,000 4,010 Total 149,061 28 149,089 90,710 Net incomellexpenditurel 148.4121 {281 148,4401 20,500 Total funds brought forward 232,072 5,175 237,247 216.747 Total funds carried forward 183,660 5,147 188,807 237,247 All of the incoming resources of the charity for the comparative year are unrestricted. All of the above results are derived from continuing aclivilies. All gains and losses recognised in the year are included above. The result for the year for Companies Act purposes is equivalent to the nel income I lexpendilurel.

The UK Oncology Nursing Society Balance Sheet 31 March 2023 Notes 2023 2022 Current assets Debtors Cash at bank and in hand 22,120 252,811 283,078 274,931 283,078 Liabilities Creditors falling due within one year 186.1241 {45,831 } Total assets less current liabilities 188,807 237,247 Unrestricted funds Restricted funds 183,660 5,147 232,072 5,175 Total funds 188,807 237,247 The directors are satisfied that the company is entitled lo exemption from the provisions of the Companies Act 2006 Ilhe Acll relating lo the audit of the financial slalemenls for the year by virtue of section 477, and that no member or members have requested an audit pursuant lo section 476 of the Act. The directors acknowledge their responsibilities for.. lil ensuring that the company keeps adequate accounting records which comply with section 386 of the Act, and lil) preparing financial statements which give a true and fair view of the state of affairs of the company as al the end of the financial year and of its profil or loss for the financial year in accordance with the requirements of sections 394 and 395, and which otherwise comply with the requirements of the Act relating to financial statements, so far as is applicable to the company. These financial statements have been prepared in accordance with the special provisions for small companies under Part 15 of the Companies Act. These financial statements were approved and signed by the Iruslees and authorised for issue on 17 Novemb8r 2023 and are signed on their behalf by- Mark Foulkes Director Company Registration Number= 06996552

The UK Oncology Nursing Society Notes to the Financial Statements Year Ended 31 March 2023 Accountlng Pollcles Basls of accountlng The principal accounting policies adopted, judgements and key sources of estimation uncertainty in the preparation of the financial statements are as follows.. a) Basis of preparation of financial statements and assessment of going Concern The financial statements have been prepared under the historical cost convention and in accordance with Accounting and Reporting by Charities.. Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland IFRS 1021 leffeclive 1 January 2019) - (Charities SORP IFRS 10211, the Financial Reporting Sl8nd8rd applicable in the UK and Republic of Ireland IFRS 102) and the Companies Act 2006. The UK Oncology Nursing Society meets the definition of a public benefit entity under FRS 102. Assets and liabilities are initially recognised al historical cost or transaction value unless otherwise stsled in the relevant accounting policy notes. The functional and presentational currency of these financial statements is sterling. The trustees consider that there are no material uncertainties about the Charity's ability lo continue as a going concern. b) Income Income is recognised when the charity has entitlement to funds, any performance conditions attached to the items of income have been mel, il is probable that the income will be received and the amount can be measured reliably. Capital grants receivable are credited to the SOFA as they become receivable and are treated as reslrirted funds. The depreciation on the assets to which the grants relate is charged against these funds. c) Fund accounting Unrestricted funds are funds available for use at the discretion of the Iruslees in furtherance of the general objectives of the charity and which have not been designated for other purposes. Restricted funds are funds received which are to be used in accordance with specific restrictions imposed by donors or which have been raised by the charity for particular purposes. d) Expenditure Expenditure is recognised once there is a legal or conslruclive obligation commilling the charity to that expenditure, il is probable that selllemenl will be required and the amount of the obligation can be measured reliably. Expenditure includes irrecoverable VAT. e) Flnanclal Instruments Financial instruments are classified and accounted for, according lo the substsnce of the contractual arrangement, as financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities. The company holds the following financial instruments, all of which are considered lo be basic.. Short term debtors and creditors Cash and bank balances

The UK Oncology Nursing Society Notes to the Financial Statements Year Ended 31 March 2023 Related Party Transactions During the year travel expenses of £12,164 were reimbursed lo 15 Iruslees {2022.' £1,606 10 10 trusleesl. Company Limited by Guarantee The company is limited by guarantee and has no share capital. In the event of a winding-up, the liability of the members is limited to £1 each. The Charity is incorporated in England and Wales. The address of its registered office is.. Legalinx, 14-18 City Road, Cardiff, Wales, CF24 3DL. Debtors 2023 2022 Trade debtors Prepayments and accrLJed income 20.005 2,115 22.120 Creditors.. amounts falling due within one year 2023 2022 Accruals and deferred income VAT payable Other creditors 62,059 3.709 20.356 86.124 21,955 3,020 20,856 45,831 Analysis of movgmgnt on funds Balance at 1 April 2022 Balance at 31 March 2023 Incoming Resources resources expended Total unreslricled funds 232,072 100,649 1149,0611 183.660 Reslricled funds.. AOS education grant EBN book grant 2,230 2,945 237,247 2,230 2,917 188.807 {281 1149,0891 100,649 The AOS education grant represents funds raised for the development of a digital friendly formal for UKONS guidance for assessment of patients. The EBN book grant represents funds raised for the writing and publication of a reference book entitled "Fundamentals of Cancer Care". The reslricled funds are all held as cash at bank and in hand.

The UK Oncology Nursing Society

Trustees’ Report

Year Ended 31 March 2023

The trustees have pleasure in presenting their report and the unaudited financial statements of the charitable company for the year ended 31 March 2023.

Status

The charitable company is also known as UKONS.

Objects and Activities of the Charity

The objects of the charitable company are, for the public benefit:

To advance health and to relieve those in need by reason of ill-health, including without limitation people affected by cancer; and
To advance the education of the public in the subjects of health, medical and nursing care, including without limitation the causes, effects and treatments of cancer.

Aims of the charity

To promote excellence in the nursing care and management of all those directly and indirectly affected by cancer.
To encourage and facilitate the personal and professional development of nurses engaged in cancer care throughout the UK and overseas through education, research and policy.
To share information about research, learning and development opportunities with UKONS members.
To contribute to the development of cancer policy, clinical practice and service delivery nationally and internationally.
To foster alliances and develop UK and international networking opportunities.

Activities and achievements aligned to the charity’s aims for the year 2022/23

Continuation of the Members Interest Groups: Living with and Beyond Cancer; Acute Oncology Services; Systemic Anti-cancer Treatments; Radiotherapy; Haemato-oncology; Lead Cancer Nurses; Research and our newest Members Interest Group- ‘Young and Early Career Cancer Nurses’
Continuation of our provision of the UKONS website (www.ukons.org), catering to the needs of members and the members interest groups.
Continued publication of fortnightly editions of UKONS ‘Breaking News’ bulletin, supporting practice development and career progression, which is sent to all members via e-mail. This includes cancer nurse job advertisements for UKONS members. These advertisements are provided free of charge to advertisers.
During 2022/23 Breaking News continued to be delivered jointly between UKONS and Macmillan Cancer Care due to an ongoing and developing partnership. This was underpinned by an MOU agreed and signed by both parties, renewed in 2022.
In November 2022 we held our first face to face annual conference since the COVID pandemic in 2020. This was held in Belfast UK and was very successful with a record number of delegates registering and attending with the highest number of poster submissions ever received in UKONS history. The event focussed on a theme of ‘Cancer Care in the Digital Age’. This provided the opportunity for cancer nurses to discuss, and present posters on supportive cancer

The UK Oncology Nursing Society

Trustees’ Report

Year Ended 31 March 2023

year it was again presented in electronic format and it is likely that it will continue to be produced in in this form annually.
UKONS continued to work with the Global Power of Oncology Nursing to support and facilitate their conference during 2023.
Work continued to produce a web-based version of the UKONS Systemic Anti-cancer Therapy (SACT) Competency Passport together with our partner is Tefogo Ltd. We aim to deliver this enhancement free to UKONS members during late 2023.
During 2022/23 UKONS continued to chair the UK SACT Board (formally UK Chemotherapy Board) delivering guidelines across all four nations for the delivery of systemic anti-cancer therapies
UKONS continued to be a central organisation in developing and delivering the ACCEND (Aspirant Cancer Career and Education Development) programme. This career framework provides guidance and structure or all health care professionals wishing to develop a career in cancer care.
Continued to approve translations of the UKONS Acute Oncology Triage Tool as well as working to formalise and deliver electronic versions of the tool.
UKONS worked in partnership with the UK Acute Oncology Society and Macmillan to standardise AO education, training and assessment and advanced work on multi-professional AO competency passports, these will be piloted in mid-2023.
Work commenced and continued on a book on the impact of the COVID pandemic in cancer care across Europe in partnership with Springer Press.
Organised and presented education, training sessions and symposia at virtual and face-to-face events for both UKONS and other organisations throughout the year, including the UK Oncology Forum and the Oncology Professional Care Conference.
Further developed the activities of UKONS Champions, with Young and Early Career Cancer Nurse input into a wide range of programmes and events. The champions worked to establish a sub-groups for both UKONS board alumni and Cancer Information Nurses.
In 2023 UKONS hosted the European Cancer Nursing Day in Edinburgh, Scotland in partnership with the European Oncology Nursing Society (EONS).
Continued to work with a wide range of industry partners and develop further relationships, extending our numbers of partners to more than 20.
Collaborated with: NHS England, UK Oncology Forum; British Journal of Nursing; Cancer Nursing Practice, The European Oncology Nursing Society (EONS); International Society of Nurses in Cancer Care (ISNCC); and Oncology Professional Care
Representation at the UK Chemotherapy Board; various NHS Working Groups (including those on SACT Capacity and Workforce); Macmillan Cancer Support/HEE.

Organisational Structure

Assessment of going concern

The UK Oncology Nursing Society

Trustees’ Report

Year Ended 31 March 2023

Directors and Trustees

The directors and trustees who served the company during the year and up to the date of this report were as follows:

Reserves

The Trustees plan to retain a modest level of reserves as a contingency fund against future demands on the charity’s resources whilst using available funds to further our charitable aims.

Small Company Provisions

This report has been prepared in accordance with the special provisions for small companies under Part 15 of the Companies Act 2006.

Signed on behalf of the directors

Mark Foulkes Director

Approved on ……31[st] August 2023